Patents by Inventor Christian Bertl

Christian Bertl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240400700
    Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.
    Type: Application
    Filed: May 16, 2024
    Publication date: December 5, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Sandra Berndt, Christian Bertling, Pascale Buchmann, Philipp Ellinger, Katharina Filarsky, Matyas Gorjanacz, Sabine Maria Hoff, Nikolaus Pawlowski, Helge Roider, Beatrix Stelte-Ludwig, Mark Trautwein, Ernst Weber, Uwe Gritzan, Oliver von Ahsen, Christian Votsmeier, Wiebke Maria Nadler, Patrick Jones, Pedro Paz, Su-Yi Tseng, Phaik Lyn Oh
  • Publication number: 20240376218
    Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.
    Type: Application
    Filed: May 16, 2024
    Publication date: November 14, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Sandra Berndt, Christian Bertling, Pascale Buchmann, Philipp Ellinger, Katharina Filarsky, Matyas Gorjanacz, Sabine Maria Hoff, Nikolaus Pawlowski, Helge Roider, Beatrix Stelte-Ludwig, Mark Trautwein, Ernst Weber, Uwe Gritzan, Oliver von Ahsen, Christian Votsmeier, Wiebke Maria Nadler, Patrick Jones, Pedro Paz, Su-Yi Tseng, Phaik Lyn Oh
  • Patent number: 12065497
    Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.
    Type: Grant
    Filed: April 22, 2022
    Date of Patent: August 20, 2024
    Assignee: Bayer Aktiengesellschaft
    Inventors: Sandra Berndt, Christian Bertling, Pascale Buchmann, Philipp Ellinger, Katharina Filarsky, Matyas Gorjanacz, Sabine Hoff, Nikolaus Pawlowski, Helge Roider, Beatrix Stelte-Ludwig, Mark Trautwein, Ernst Weber, Uwe Gritzan, Oliver von Ahsen, Christian Votsmeier, Wiebke Maria Nadler, Patrick Jones, Pedro Paz, Su-Yi Tseng, Phaik Lyn Oh
  • Publication number: 20230141280
    Abstract: Cured silicone rubbers for acoustic damping, and formulations and methods used to make the same, are provided.
    Type: Application
    Filed: October 28, 2022
    Publication date: May 11, 2023
    Inventors: Andrei Gavryushin, Christian Bertl, Juergen Sauer
  • Publication number: 20220243063
    Abstract: Cured silicone rubbers for acoustic damping, and formulations and methods used to make the same, are provided.
    Type: Application
    Filed: January 26, 2022
    Publication date: August 4, 2022
    Inventors: Andrei Gavryushin, Christian Bertl, Juergen Sauer
  • Publication number: 20210281962
    Abstract: A composite material for producing an acoustic membrane, wherein the composite material comprises a silicone layer comprising an at least partially uncured silicone rubber and a support layer, wherein the support layer is adjacent to the silicone layer, as well as a method of preparing such a composite material and a process for producing an acoustic membrane from such a composite material.
    Type: Application
    Filed: July 4, 2017
    Publication date: September 9, 2021
    Inventors: Christian Zechner, Peter Pertl, José Antonio Garcia Garcia, Christian Bertl
  • Publication number: 20190098423
    Abstract: Acoustic membrane (100) comprising at least three layers with a first outer layer (101) and a second outer layer (102), wherein the first and the second outer layer (101, 102) are formed by a thermoplastic elastomer, wherein the thermoplastic elastomer forming the first outer layer and the thermoplastic elastomer forming the second outer layer are independently from each other selected from the group consisting of polyester elastomers, co-polyester elastomers, styrene block copolymers, elastic co-polyamides, thermoplastic silicones, and elastomeric polyolefins, preferably co-polyester elastomers.
    Type: Application
    Filed: April 25, 2017
    Publication date: March 28, 2019
    Inventors: Christian Zechner, Peter Pertl, Christian Bertl